Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)
Clinical trial NCT06593600 · COMPLETED
Trial details
- NCT number
- NCT06593600
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-13
- Primary completion
- 2026-05-06
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.